ArticleJournal of biological engineering2025

Engineered neutrophil engagers overcome IgA limitations and reprogram resting neutrophils for cancer immunotherapy.

Jisun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.